相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Adipose tissue remodelling in obese subjects is a determinant of presence and severity of fatty liver disease
Flavia Agata Cimini et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2021)
Improving Care and Promoting Health in Populations: Standards of Medical Care in Diabetes-2020
DIABETES CARE (2020)
Significance of circulatory DPP4 activity in metabolic diseases
Titli Nargis et al.
IUBMB LIFE (2018)
Nonalcoholic fatty liver disease and chronic vascular complications of diabetes mellitus
Giovanni Targher et al.
NATURE REVIEWS ENDOCRINOLOGY (2018)
Serum IP-10 levels and increased DPPIV activity are linked to circulating CXCR3+T cells in cholestatic HCV patients
Monika Rau et al.
PLOS ONE (2018)
Hepatic DPP4 DNA Methylation Associates With Fatty Liver
Christian Baumeier et al.
DIABETES (2017)
The pro-fibrotic role of dipeptidyl peptidase 4 in carbon tetrachloride-induced experimental liver injury
Xin M. Wang et al.
IMMUNOLOGY AND CELL BIOLOGY (2017)
Association of plasma dipeptidyl peptidase-4 activity with non-alcoholic fatty liver disease in nondiabetic Chinese population
Tianpeng Zheng et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2017)
Elevated hepatic DPP4 activity promotes insulin resistance and non-alcoholic fatty liver disease
Christian Baumeier et al.
MOLECULAR METABOLISM (2017)
Altered circulating concentrations of active glucagon-like peptide (GLP-1) and dipeptidyl peptidase 4 (DPP4) in obese subjects and their association with insulin resistance
Radwan H. Ahmed et al.
CLINICAL BIOCHEMISTRY (2017)
Serum Levels of Soluble CD26/Dipeptidyl Peptidase-IV in Type 2 Diabetes Mellitus and Its Association with Metabolic Syndrome and Therapy with Antidiabetic Agents in Malaysian Subjects
Radwan H. Ahmed et al.
PLOS ONE (2015)
Circulating dipeptidyl peptidase-4 activity correlates with measures of hepatocyte apoptosis and fibrosis in non-alcoholic fatty liver disease in type 2 diabetes mellitus and obesity: A dual cohort cross-sectional study
Kathryn H. Williams et al.
JOURNAL OF DIABETES (2015)
Obese patients have higher circulating protein levels of dipeptidyl peptidase IV
Andreas Stengel et al.
PEPTIDES (2014)
Adipose Dipeptidyl Peptidase-4 and Obesity Correlation with insulin resistance and depot-specific release from adipose tissue in vivo and in vitro
Henrike Sell et al.
DIABETES CARE (2013)
Simple Noninvasive Systems Predict Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease
Paul Angulo et al.
GASTROENTEROLOGY (2013)
Dipeptidyl peptidase-4: A key player in chronic liver disease
Minoru Itou et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2013)
Method comparison of dipeptidyl peptidase IV activity assays and their application in biological samples containing reversible inhibitors
Veerle Matheeussen et al.
CLINICA CHIMICA ACTA (2012)
Association Between Nonalcoholic Fatty Liver Disease and Risk for Hepatocellular Cancer, Based on Systematic Review
Donna L. White et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2012)
The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association
Naga Chalasani et al.
HEPATOLOGY (2012)
Increased hepatic expression of dipeptidyl peptidase-4 in non-alcoholic fatty liver disease and its association with insulin resistance and glucose metabolism
Masayuki Miyazaki et al.
MOLECULAR MEDICINE REPORTS (2012)
Serum level of soluble CD26/dipeptidyl peptidase-4 (DPP-4) predicts the response to sitagliptin, a DPP-4 inhibitor, in patients with type 2 diabetes controlled inadequately by metformin and/or sulfonylurea
Yoshimasa Aso et al.
TRANSLATIONAL RESEARCH (2012)
Dipeptidyl Peptidase 4 Is a Novel Adipokine Potentially Linking Obesity to the Metabolic Syndrome
Daniela Lamers et al.
DIABETES (2011)
Serum Dipeptidyl Peptidase-4 Activity in Insulin Resistant Patients with Non-Alcoholic Fatty Liver Disease: A Novel Liver Disease Biomarker
Gabor Firneisz et al.
PLOS ONE (2010)
Comparison of Noninvasive Markers of Fibrosis in Patients With Nonalcoholic Fatty Liver Disease
Amy G. Shah et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2009)
Dipeptidyl peptidase IV (DDP IV) in NASH patients
Yasemin H. Balaban et al.
ANNALS OF HEPATOLOGY (2007)
Diagnosis and management of the metabolic syndrome - An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement
SM Grundy et al.
CIRCULATION (2005)
Design and validation of a histological scoring system for nonalcoholic fatty liver disease
DE Kleiner et al.
HEPATOLOGY (2005)
Dipeptidyl peptidase IV and related enzymes in cell biology and liver disorders
MD Gorrell
CLINICAL SCIENCE (2005)
Impact of liver biopsy size on histological evaluation of chronic viral hepatitis: the smaller the sample, the milder the disease
G Colloredo et al.
JOURNAL OF HEPATOLOGY (2003)
分享论文
